Literature DB >> 28193705

Outcome-Driven Thresholds for Increased Home Blood Pressure Variability.

Eeva P Juhanoja1, Teemu J Niiranen2, Jouni K Johansson2, Pauli J Puukka2, Lutgarde Thijs2, Kei Asayama2, Ville L Langén2, Atsushi Hozawa2, Lucas S Aparicio2, Takayoshi Ohkubo2, Ichiro Tsuji2, Yutaka Imai2, George S Stergiou2, Antti M Jula2, Jan A Staessen2.   

Abstract

Increased blood pressure (BP) variability predicts cardiovascular disease, but lack of operational thresholds limits its use in clinical practice. Our aim was to define outcome-driven thresholds for increased day-to-day home BP variability. We studied a population-based sample of 6238 individuals (mean age 60.0±12.9, 56.4% women) from Japan, Greece, and Finland. All participants self-measured their home BP on ≥3 days. We defined home BP variability as the coefficient of variation of the first morning BPs on 3 to 7 days. We assessed the association between systolic/diastolic BP variability (as a continuous variable and in deciles of coefficient of variation) and cardiovascular outcomes using Cox regression models adjusted for cohort and classical cardiovascular risk factors, including BP. During a follow-up of 9.3±3.6 years, 304 cardiovascular deaths and 715 cardiovascular events occurred. A 1 SD increase in systolic/diastolic home BP variability was associated with increased risk of cardiovascular mortality (hazard ratio, 1.17/1.22; 95% confidence interval, 1.06-1.30/1.11-1.34; P=0.003/<0.0001) and cardiovascular events (hazard ratio, 1.13/1.14; 95% confidence interval, 1.05-1.21/1.07-1.23; P=0.0007/0.0002). Compared with the average risk in the whole population, risk of cardiovascular deaths (hazard ratio, 1.66/1.84; 95% confidence interval, 1.27-2.17/1.42-2.37; P=0.0002/<0.0001) and events (hazard ratio, 1.46/1.42; 95% confidence interval, 1.21-1.76/1.17-1.71; P<0.0001/0.0004) was increased in the highest decile of systolic/diastolic BP variability (coefficient of variation>11.0/12.8). Increased home BP variability predicts cardiovascular outcomes in the general population. Individuals with a systolic/diastolic coefficient of variation of day-to-day home BP >11.0/12.8 may have an increased risk of cardiovascular disease. These findings could help physicians identify individuals who are at an increased cardiovascular disease risk.
© 2017 American Heart Association, Inc.

Entities:  

Keywords:  blood pressure; epidemiology; hypertension; risk factors

Mesh:

Year:  2017        PMID: 28193705     DOI: 10.1161/HYPERTENSIONAHA.116.08603

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  22 in total

1.  Blood Pressure Variability Predicts Clinical Outcomes: Now What?

Authors:  Jeff Whittle
Journal:  Hypertension       Date:  2017-02-13       Impact factor: 10.190

2.  Within-Visit Blood Pressure Variability and Cardiovascular Risk in ELSA-Brasil Study Participants.

Authors:  André Sant'Anna Zarife; Helena Fraga-Maia; José Geraldo Mill; Paulo Lotufo; Rosane Harter Griep; Maria de Jesus Mendes da Fonseca; Luciara Leite Brito; Maria da Conceição Almeida; Roque Aras; Sheila Maria Alvim Matos
Journal:  Arq Bras Cardiol       Date:  2022-09-02       Impact factor: 2.667

Review 3.  A personal history of research on hypertension From an encounter with hypertension to the development of hypertension practice based on out-of-clinic blood pressure measurements.

Authors:  Yutaka Imai
Journal:  Hypertens Res       Date:  2022-09-08       Impact factor: 5.528

4.  Elevated levels of body mass index and waist circumference, but not high variability, are associated with an increased risk of atrial fibrillation.

Authors:  Maoxiang Zhao; Lulu Song; Qianqian Zhao; Yating Chen; Bin Li; Zhonghui Xie; Zihao Fu; Nan Zhang; Xiaowei Cheng; Xiaoqian Li; Miao Wang; Shouling Wu; Hao Xue; Yang Li
Journal:  BMC Med       Date:  2022-06-29       Impact factor: 11.150

Review 5.  Blood pressure variability: its relevance for cardiovascular homeostasis and cardiovascular diseases.

Authors:  Gianfranco Parati; Camilla Torlasco; Martino Pengo; Grzegorz Bilo; Juan Eugenio Ochoa
Journal:  Hypertens Res       Date:  2020-03-13       Impact factor: 3.872

Review 6.  Blood Pressure Variability and Autonomic Dysfunction.

Authors:  Vincenza Spallone
Journal:  Curr Diab Rep       Date:  2018-10-25       Impact factor: 4.810

7.  Acupuncture for patients with mild hypertension: A randomized controlled trial.

Authors:  Hui Zheng; Juan Li; Ying Li; Ling Zhao; Xi Wu; Jie Chen; Xiang Li; Yin-Lan Huang; Xiao-Rong Chang; Mi Liu; Jin Cui; Rui-Hui Wang; Xu Du; Jing Shi; Tai-Pin Guo; Fan-Rong Liang
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-02-08       Impact factor: 3.738

Review 8.  Blood pressure monitoring in sleep: time to wake up.

Authors:  Younghoon Kwon; Patrick L Stafford; Diane C Lim; Sungha Park; Sung-Hoon Kim; Richard B Berry; David A Calhoun
Journal:  Blood Press Monit       Date:  2020-04       Impact factor: 1.430

9.  Home blood pressure control status in 2017-2018 for hypertension specialist centers in Asia: Results of the Asia BP@Home study.

Authors:  Kazuomi Kario; Naoko Tomitani; Peera Buranakitjaroen; Yook-Chin Chia; Sungha Park; Chen-Huan Chen; Romeo Divinagracia; Jinho Shin; Saulat Siddique; Jorge Sison; Arieska Ann Soenarta; Guru Prasad Sogunuru; Jam Chin Tay; Yuda Turana; Yuqing Zhang; Jennifer Nailes; Sirisawat Wanthong; Satoshi Hoshide; Noriko Matsushita; Hiroshi Kanegae; Ji-Guang Wang
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-11-16       Impact factor: 3.738

10.  Association of self-measured home, ambulatory, and strictly measured office blood pressure and their variability with intracranial arterial stenosis.

Authors:  Takashi Hisamatsu; Takayoshi Ohkubo; Atsushi Hozawa; Akira Fujiyoshi; Sayuki Torii; Hiroyoshi Segawa; Keiko Kondo; Aya Kadota; Naoyuki Takashima; Satoshi Shitara; Hisatomi Arima; Yoshihisa Nakagawa; Yoshiyuki Watanabe; Akihiko Shiino; Kazuhiko Nozaki; Hirotsugu Ueshima; Katsuyuki Miura
Journal:  J Hypertens       Date:  2021-10-01       Impact factor: 4.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.